Clinical Trial Update: Efficacy and Safety Study of Meditoxin® to Treat Essential Blepharospasm [Phase 4]

View source ↗

Summary

Phase 4 study assessing the efficacy and safety of Meditoxin for blepharospasm, essential type, has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Blepharospasm Essential

Drugs mentioned

• Meditoxin (botulinum toxin type A)

Snippet

Sponsor: Medy-Tox | Conditions: Essential Blepharospasm | Phase 4 | Status: COMPLETED